1. Home
  2. ENTA vs REKR Comparison

ENTA vs REKR Comparison

Compare ENTA & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • REKR
  • Stock Information
  • Founded
  • ENTA 1995
  • REKR 2017
  • Country
  • ENTA United States
  • REKR United States
  • Employees
  • ENTA N/A
  • REKR N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • REKR Telecommunications Equipment
  • Sector
  • ENTA Health Care
  • REKR Telecommunications
  • Exchange
  • ENTA Nasdaq
  • REKR Nasdaq
  • Market Cap
  • ENTA 164.6M
  • REKR 147.6M
  • IPO Year
  • ENTA 2013
  • REKR N/A
  • Fundamental
  • Price
  • ENTA $7.51
  • REKR $1.14
  • Analyst Decision
  • ENTA Buy
  • REKR
  • Analyst Count
  • ENTA 5
  • REKR 0
  • Target Price
  • ENTA $18.40
  • REKR N/A
  • AVG Volume (30 Days)
  • ENTA 173.3K
  • REKR 2.7M
  • Earning Date
  • ENTA 08-08-2025
  • REKR 08-12-2025
  • Dividend Yield
  • ENTA N/A
  • REKR N/A
  • EPS Growth
  • ENTA N/A
  • REKR N/A
  • EPS
  • ENTA N/A
  • REKR N/A
  • Revenue
  • ENTA $64,462,999.00
  • REKR $45,448,000.00
  • Revenue This Year
  • ENTA N/A
  • REKR $8.68
  • Revenue Next Year
  • ENTA $2.75
  • REKR $21.45
  • P/E Ratio
  • ENTA N/A
  • REKR N/A
  • Revenue Growth
  • ENTA N/A
  • REKR 17.97
  • 52 Week Low
  • ENTA $4.09
  • REKR $0.62
  • 52 Week High
  • ENTA $15.92
  • REKR $2.67
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 51.19
  • REKR 41.91
  • Support Level
  • ENTA $7.15
  • REKR $1.09
  • Resistance Level
  • ENTA $8.31
  • REKR $1.42
  • Average True Range (ATR)
  • ENTA 0.48
  • REKR 0.08
  • MACD
  • ENTA 0.01
  • REKR -0.02
  • Stochastic Oscillator
  • ENTA 55.73
  • REKR 14.88

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About REKR Rekor Systems Inc.

Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.

Share on Social Networks: